Silencing SIRT1 increases epithelial markers and decreases mesenchymal markers, suggesting that SIRT1 promotes EMT (epithelial–mesenchymal transition) in glioma cells, facilitating their invasive capabilities [51]. This evidence concerns the gene SIRT1 and glioma.